Finding 575507 (2024-003)

Significant Deficiency
Requirement
L
Questioned Costs
-
Year
2024
Accepted
2025-09-03
Audit: 365488
Organization: Avivo (MN)

AI Summary

  • Core Issue: The Organization failed to submit the financial report on time and lacked evidence of review for the performance report.
  • Impacted Requirements: This violates Uniform Grant Guidance (2 CFR 200.303), which mandates effective internal controls for compliance with federal reporting requirements.
  • Recommended Follow-Up: The Organization should enhance its procedures to ensure timely submission of reports and implement a formal review process before submission.

Finding Text

Federal Agency: U.S. Department of Health and Human Services Federal Program Name: Substance Abuse and Mental Health Services Projects of Regional and National Significance Assistance Listing Number: 93.243 Federal Award Identification Number and Year: H79TI080845 Pass-Through Agency: N/A Pass-Through Number(s): N/A Award Period: January 1, 2024 – December 31, 2024 Type of Finding: Significant Deficiency in Internal Control over Compliance Criteria or specific requirement: Uniform Grant Guidance (2 CFR 200.303) requires non-Federal entities receiving Federal awards establish and maintain internal controls designed to reasonably ensure compliance with Federal laws, regulations, and program compliance requirements. Effective internal controls should include procedures to ensure reimbursement requests are formally reviewed by someone who did not prepare the request to verify the correct information and data is submitted. Condition: The Organization submitted the financial report after the required due date and the performance report did not have evidence of review or approval. Questioned costs: None Context: During our testing, we identified the financial report was submitted after the required due date and the performance report did not have evidence of review or approval. Cause: The Organization did not submit financial report timely and performance report did not have evidence of control. Effect: The Organization did not meet the reporting requirements for submitting financial reports timely. Additionally, one performance report did not have evidence of a review performed. Repeat Finding: No Recommendation: We recommend the entity evaluate its procedures and implement an additional control to ensure reports are submitted timely and reviewed prior to submission.

Corrective Action Plan

Substance Abuse and Mental Health Services Projects of Regional and National Significance – Assistance Listing No. 93.243 Recommendation: We recommend the entity evaluate its procedures and implement an additional control to ensure reports are submitted timely and reviewed prior to submission. Explanation of disagreement with audit finding: There is no disagreement with the audit finding. Action taken in response to finding: Avivo will implement an enhanced internal review process to ensure timely report submission and accuracy prior to submission. This will include assigning dedicated personnel to track submission deadlines and conducting pre-submission reviews for completeness and accuracy. Name(s) of the contact person(s) responsible for corrective action: Heidi Kammer-Hodge & Kristen Bewley. Planned completion date for corrective action plan: December 2025.

Categories

Cash Management Reporting Significant Deficiency Matching / Level of Effort / Earmarking Internal Control / Segregation of Duties

Other Findings in this Audit

  • 575475 2024-001
    Significant Deficiency
  • 575476 2024-001
    Significant Deficiency
  • 575477 2024-001
    Significant Deficiency
  • 575478 2024-001
    Significant Deficiency
  • 575479 2024-001
    Significant Deficiency
  • 575480 2024-001
    Significant Deficiency
  • 575481 2024-001
    Significant Deficiency
  • 575482 2024-001
    Significant Deficiency
  • 575483 2024-001
    Significant Deficiency
  • 575484 2024-001
    Significant Deficiency
  • 575485 2024-001
    Significant Deficiency
  • 575486 2024-001
    Significant Deficiency
  • 575487 2024-001
    Significant Deficiency
  • 575488 2024-001
    Significant Deficiency
  • 575489 2024-001
    Significant Deficiency
  • 575490 2024-001
    Significant Deficiency
  • 575491 2024-002
    Significant Deficiency
  • 575492 2024-002
    Significant Deficiency
  • 575493 2024-002
    Significant Deficiency
  • 575494 2024-002
    Significant Deficiency
  • 575495 2024-002
    Significant Deficiency
  • 575496 2024-002
    Significant Deficiency
  • 575497 2024-002
    Significant Deficiency
  • 575498 2024-002
    Significant Deficiency
  • 575499 2024-002
    Significant Deficiency
  • 575500 2024-002
    Significant Deficiency
  • 575501 2024-002
    Significant Deficiency
  • 575502 2024-002
    Significant Deficiency
  • 575503 2024-002
    Significant Deficiency
  • 575504 2024-002
    Significant Deficiency
  • 575505 2024-002
    Significant Deficiency
  • 575506 2024-002
    Significant Deficiency
  • 1151917 2024-001
    Significant Deficiency
  • 1151918 2024-001
    Significant Deficiency
  • 1151919 2024-001
    Significant Deficiency
  • 1151920 2024-001
    Significant Deficiency
  • 1151921 2024-001
    Significant Deficiency
  • 1151922 2024-001
    Significant Deficiency
  • 1151923 2024-001
    Significant Deficiency
  • 1151924 2024-001
    Significant Deficiency
  • 1151925 2024-001
    Significant Deficiency
  • 1151926 2024-001
    Significant Deficiency
  • 1151927 2024-001
    Significant Deficiency
  • 1151928 2024-001
    Significant Deficiency
  • 1151929 2024-001
    Significant Deficiency
  • 1151930 2024-001
    Significant Deficiency
  • 1151931 2024-001
    Significant Deficiency
  • 1151932 2024-001
    Significant Deficiency
  • 1151933 2024-002
    Significant Deficiency
  • 1151934 2024-002
    Significant Deficiency
  • 1151935 2024-002
    Significant Deficiency
  • 1151936 2024-002
    Significant Deficiency
  • 1151937 2024-002
    Significant Deficiency
  • 1151938 2024-002
    Significant Deficiency
  • 1151939 2024-002
    Significant Deficiency
  • 1151940 2024-002
    Significant Deficiency
  • 1151941 2024-002
    Significant Deficiency
  • 1151942 2024-002
    Significant Deficiency
  • 1151943 2024-002
    Significant Deficiency
  • 1151944 2024-002
    Significant Deficiency
  • 1151945 2024-002
    Significant Deficiency
  • 1151946 2024-002
    Significant Deficiency
  • 1151947 2024-002
    Significant Deficiency
  • 1151948 2024-002
    Significant Deficiency
  • 1151949 2024-003
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance $763,532
17.289 Community Project Funding/congressionally Directed Spending $599,443
14.231 Emergency Solutions Grant Program $598,950
14.218 Community Development Block Grants/entitlement Grants $383,467
93.136 Injury Prevention and Control Research and State and Community Based Programs $165,027
93.558 Temporary Assistance for Needy Families $137,028
93.788 Opioid Str $131,237
21.027 Coronavirus State and Local Fiscal Recovery Funds $63,057
17.259 Wioa Youth Activities $35,912
17.258 Wioa Adult Program $34,048
93.959 Block Grants for Prevention and Treatment of Substance Abuse $23,229
93.958 Block Grants for Community Mental Health Services $19,324
93.566 Refugee and Entrant Assistance State/replacement Designee Administered Programs $18,767
93.575 Child Care and Development Block Grant $13,156
17.278 Wioa Dislocated Worker Formula Grants $12,925
10.561 State Administrative Matching Grants for the Supplemental Nutrition Assistance Program $3,283
14.267 Continuum of Care Program $1,542